Discounted Cash Flow Rating

Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

ClearPoint Neuro, Inc. Common Stock (CLPT)

Surgical & Medical Instruments & Apparatus

https://www.clearpointneuro.com

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace is used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint neuro system, MRI-guided drug delivery, and Thermal therapy system.

120 S. SIERRA AVENUE, SUITE 100
SOLANA BEACH, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/18/2012

Market Cap

300,461,982

Shares Outstanding

24,620,000

Weighted SO

24,620,567

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

TBIO --.--%

TBIO --.--%

RCEL --.--%

RCEL --.--%

SGHT --.--%

TMCI --.--%

NPCE --.--%

INGN --.--%

INGN --.--%

Beta

1.0750

Last Div

0.0000

Range

4.05-11.38

Chg

0.0480

Avg Vol

230304

Mkt Cap

300461982

Exch

NASDAQ

Country

US

Phone

888 287 9109

DCF Diff

7.1611

DCF

-0.0211

Div Yield

0.0000

P/S

10.7044

EV Multiple

-16.3499

P/FV

9.3077

Div Yield %

0.0000

P/E

-16.6319

PEG

-0.7913

Payout

0.0000

Current Ratio

2.7888

Quick Ratio

2.3077

Cash Ratio

1.9675

DSO

58.8546

DIO

260.0989

Op Cycle

318.9535

DPO

26.6220

CCC

292.3315

Gross Margin

0.5985

Op Margin

-0.6617

Pretax Margin

-0.6406

Net Margin

-0.6406

Eff Tax Rate

-0.0405

ROA

-0.3420

ROE

-0.6423

ROCE

-0.5176

NI/EBT

1.0000

EBT/EBIT

0.9682

EBIT/Rev

-0.6617

Debt Ratio

0.2624

D/E

0.4294

LT Debt/Cap

0.0932

Total Debt/Cap

0.3004

Int Coverage

-97.2408

CF/Debt

-0.6866

Equity Multi

1.6362

Rec Turnover

6.2017

Pay Turnover

13.7105

Inv Turnover

1.4033

FA Turnover

5.7577

Asset Turnover

0.5339

OCF/Share

-0.3449

FCF/Share

-0.3603

Cash/Share

1.1957

OCF/Sales

-0.3375

FCF/OCF

1.0447

CF Coverage

-0.6866

ST Coverage

-0.9026

CapEx Coverage

-22.3948

Div&CapEx Cov

-22.3948

P/BV

9.3077

P/B

9.3077

P/S

10.7044

P/E

-16.6319

P/FCF

-30.3620

P/OCF

-31.5714

P/CF

-31.5714

PEG

-0.7913

P/S

10.7044

EV Multiple

-16.3499

P/FV

9.3077

DPS

0.0000

Latest Headlines (EST)

Benzinga Oct 24, 11:00 Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023

Revenue Product Segmentation